Citation Impact
Citing Papers
Platelet gene expression and function in patients with COVID-19
2020 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Tumor-Derived Tissue FactorBearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy
2009
Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
2011
Critical review: vegetables and fruit in the prevention of chronic diseases
2012 Standout
Current knowledge on exosome biogenesis and release
2017 Standout
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Role of prothrombin complex concentrate in perioperative coagulation therapy
2014
Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial
2009
Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma
2010
Quantification of hypercoagulable state after blunt trauma: Microparticle and thrombin generation are increased relative to injury severity, while standard markers are not
2012
Mechanisms of Thrombus Formation
2008 Standout
Microparticle-mediated thrombin generation assay: increased activity in patients with recurrent thrombosis
2008
An international external quality assessment for laboratory diagnosis of heparin‐induced thrombocytopenia
2019
Triggers, targets and treatments for thrombosis
2008 Nature
High rate of unprovoked recurrent venous thrombosis is associated with high thrombin‐generating potential in a prospective cohort study
2008
Physical Principles of Membrane Shape Regulation by the Glycocalyx
2019 StandoutNobel
Platelet functions and clinical effects in acute myelogenous leukemia
2007
Cancer to bone: a fatal attraction
2011 Standout
Contribution of platelets to tumour metastasis
2011 Standout
Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles
2009
Evidence of platelet activation in multiple sclerosis
2008
Is thrombin generation at the time of an acute thromboembolic episode a predictor of recurrence? The LInköping Study on Thrombosis (LIST) – A 7-year follow-up
2012 StandoutNobel
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
2016
Comparison between idiopathic deep vein thrombosis of the upper and lower extremity regarding risk factors and recurrence
2008
Platelets and acute cerebral infarction
2012 StandoutNobel
Antithrombotic Therapy for VTE Disease
2016 Standout
Platelet activation and reactivity in the convalescent phase of ischaemic stroke
2010
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Clearance of platelet microparticles in vivo
2011
Thrombin generation: a comparison of assays using platelet‐poor and ‐rich plasma and whole blood samples from healthy controls and patients with a history of venous thromboembolism
2007
Contact activation: important to consider when measuring the contribution of tissue factor‐bearing microparticles to thrombin generation using phospholipid‐containing reagents
2014 StandoutNobel
Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban
2012
Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram
2009
Clinical and laboratory diagnosis of heparin induced thrombocytopenia: an update
2017
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
Guidelines for the Primary Prevention of Stroke
2010
Prevention of VTE in Nonsurgical Patients
2012 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients
2008
Differential contributions of monocyte‐ and platelet‐derived microparticles towards thrombin generation and fibrin formation and stability
2011
Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study
2009 StandoutNobel
Fluorescent particles in the antibody solution result in false TF- and CD14-positive microparticles in flow cytometric analysis
2011
Membrane microvesicles: Macromessengers in cancer disease and progression
2010
High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism
2008
Exosomes: biogenesis, biologic function and clinical potential
2019 Standout
Microparticles in Cancer
2010
Microparticles, thrombosis and cancer
2009
Potential roles of cell-derived microparticles in ischemic brain disease
2009
Asymmetric Dimethylarginine Is Increased in Chronic Thromboembolic Pulmonary Hypertension
2007
Pre-analytical and analytical issues in the analysis of blood microparticles
2010
Emerging Biological Principles of Metastasis
2017 Standout
Phospho‐inositide‐dependent kinase 1 regulates signal dependent translation in megakaryocytes and platelets
2020
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay
2009
Predictive Value of Factor V Leiden and Prothrombin G20210A in Adults With Venous Thromboembolism and in Family Members of Those With a Mutation
2009
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
Erythrocyte vesiculation: a self‐protective mechanism?
2008
Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication
2018 Standout
Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies?
2008
Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence
2007
Gasdermins: Effectors of Pyroptosis
2017 Standout
Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC–PCI complex concentration and/or soluble thrombomodulin antigen and activity
2007
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Age Sensitivity of NFκB Abundance and Programmed Cell Death in Erythrocytes Induced by NFκB Inhibitors
2013 Standout
PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway
2018
Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle
2013 StandoutNobel
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Malignant transformation in melanocytes is associated with increased production of procoagulant microvesicles
2011
Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event
2014 StandoutNobel
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism
2010
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
The Role of Tissue Factor Pathway Inhibitor in Tumor Growth and Metastasis
2007
Extracellular vesicles: Exosomes, microvesicles, and friends
2013 Standout
Exosomes
2019 Standout
Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis
2019 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Microparticles in Hemostasis and Thrombosis
2011
Cancer cell–derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo
2009
Microparticle‐associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients
2012
Guidelines for the Primary Prevention of Stroke
2014 Standout
Thrombin generation and venous thromboembolism
2008
Platelet transfusion to reverse antiplatelet therapy before decompressive surgery in patients with intracranial haemorrhage
2017
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Monitoring thrombin generation: Is addition of corn trypsin inhibitor needed?
2009
Wound Healing: A Cellular Perspective
2018 Standout
Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi
2015 Standout
Putting polyphosphates to the test: evidence against platelet-induced activation of factor XII
2013 StandoutNobel
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
An Updated Definition of Stroke for the 21st Century
2013 Standout
Standardization of sample collection, isolation and analysis methods in extracellular vesicle research
2013 Standout
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
2021 Standout
Monocytic microparticles activate endothelial cells in an IL-1β–dependent manner
2011
Prediction of venous thromboembolism in cancer patients
2010
Platelet-derived microparticles and coagulation activation in breast cancer patients
2008
Tissue factor: beyond coagulation in the cardiovascular system
2009
Works of Gregor Hron being referenced
Storage of thawed plasma for a liquid plasma bank: impact of temperature and methylene blue pathogen inactivation
2011
The cardiovascular risk marker asymmetrical dimethylarginine is not affected by venous thromboembolism
2006
Prevalence and clinical implications of anti-PF4/heparin antibodies in intensive care patients: a prospective observational study
2014
Periprocedural antiplatelet therapy: recommendations for standardized reporting in patients on antiplatelet therapy: communication from the SSC of the ISTH
2013
Prediction of recurrent venous thromboembolism by measuring ProC Global
2007
Family History for Venous Thromboembolism and the Risk for Recurrence
2006
Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time
2006
Evaluation of automated immunoassays in the diagnosis of heparin induced thrombocytopenia
2013
Identification of Patients at Low Risk for Recurrent Venous Thromboembolism by Measuring Thrombin Generation
2006
PDK1 Determines Collagen-Dependent Platelet Ca 2+ Signaling and Is Critical to Development of Ischemic Stroke In Vivo
2016
The Association between Tissue Factor-Exposing Microparticles and the Activation of the Coagulation System in Cancer Patients.
2004
Endogenous Thrombin Potential (ETP) for Assessing the Risk of Recurrent Venous Thromboembolism.
2005
Circulating P-selectin and the risk of recurrent venous thromboembolism
2007
Prediction of Recurrent Venous Thromboembolism by Endogenous Thrombin Potential and D-Dimer
2008
Tissue factor-positive microparticles: Cellular origin and association with coagulation activation in patients with colorectal cancer
2007